http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8239758

Outgoing Links

Predicate Object
contentType Journal Article
issn 2072-6694
issueIdentifier 20
pageRange 5095-
publicationName Cancers
startingPage 5095
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_db50a56f54387ffa32ba1d405e9d6652
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7c08ec6beacb44dbaa5aa6cad41ce37d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0f7bf8893a2035b438cd40754468f1b8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c4ff4a7e563fb703f499435cfd3e9b5e
bibliographicCitation Kuo CS, Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Yang CT. Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation. Cancers (Basel). 2022 Jan 09;14(2). PMID: 35053480; PMCID: PMC8773866.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09638d47fc54507ff14cd724848102b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc856bcf6bf8b77706ca12eb4beceab1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_167d41d3e91fdd3d5c4bc0e7c48919cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20f6f8249c912ad0fd82959f85f58697
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39e1f280afb483a80fbc5b33c6b9e8d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e572213b550b7a62b1e3ba618d22cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3309-937X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2932-751X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6069840e952d16a73d90fd62d63ea1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0173-7509
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1846-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca082d1a5ee5423f76875bebd896ca22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b101392c6be3c634cbf859cae9261a8e
date 2022-10-18^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC9316991
https://pubmed.ncbi.nlm.nih.gov/36291877
https://doi.org/10.3390/cancers14205095
https://pubmed.ncbi.nlm.nih.gov/35884531
https://pubmed.ncbi.nlm.nih.gov/35053480
https://doi.org/10.3390/cancers14143470
https://doi.org/10.3390/cancers14020316
isPartOf https://portal.issn.org/resource/ISSN/2072-6694
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37563
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71496458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Showing number of triples: 1 to 46 of 46.